Toll Free: 1-888-928-9744
Published: May, 2014 | Pages:
39 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
INSYS Therapeutics, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Insys Therapeutics, Inc. - Product Pipeline Review - 2014', provides an overview of the Insys Therapeutics, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Insys Therapeutics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Insys Therapeutics, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Insys Therapeutics, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Insys Therapeutics, Inc.'s pipeline products Reasons to buy - Evaluate Insys Therapeutics, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Insys Therapeutics, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Insys Therapeutics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Insys Therapeutics, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Insys Therapeutics, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Insys Therapeutics, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 INSYS Therapeutics, Inc. Snapshot 5 INSYS Therapeutics, Inc. Overview 5 Key Information 5 Key Facts 5 INSYS Therapeutics, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 INSYS Therapeutics, Inc. - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 INSYS Therapeutics, Inc. - Pipeline Products Glance 11 INSYS Therapeutics, Inc. - Clinical Stage Pipeline Products 11 Phase II Products/Combination Treatment Modalities 11 Phase I Products/Combination Treatment Modalities 12 INSYS Therapeutics, Inc. - Early Stage Pipeline Products 13 Preclinical Products/Combination Treatment Modalities 13 INSYS Therapeutics, Inc. - Drug Profiles 14 dronabinol 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 docetaxel 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 paclitaxel 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 cintredekin besudotox 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 buprenorphine hydrochloride 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 cannabidiol 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 diclofenac 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 ketorolac tromethamine 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 ondansetron hydrochloride 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 sildenafil citrate 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 INSYS Therapeutics, Inc. - Pipeline Analysis 28 INSYS Therapeutics, Inc. - Pipeline Products by Target 28 INSYS Therapeutics, Inc. - Pipeline Products by Route of Administration 30 INSYS Therapeutics, Inc. - Pipeline Products by Molecule Type 31 INSYS Therapeutics, Inc. - Pipeline Products by Mechanism of Action 32 INSYS Therapeutics, Inc. - Recent Pipeline Updates 34 INSYS Therapeutics, Inc. - Dormant Projects 35 INSYS Therapeutics, Inc. - Discontinued Pipeline Products 36 Discontinued Pipeline Product Profiles 36 SS1(dsFv)-PE38 36 INSYS Therapeutics, Inc. - Locations And Subsidiaries 37 Head Office 37 Appendix 38 Methodology 38 Coverage 38 Secondary Research 38 Primary Research 38 Expert Panel Validation 38 Contact Us 39 Disclaimer 39
List of Tables INSYS Therapeutics, Inc., Key Information 5 INSYS Therapeutics, Inc., Key Facts 5 INSYS Therapeutics, Inc. - Pipeline by Indication, 2014 8 INSYS Therapeutics, Inc. - Pipeline by Stage of Development, 2014 9 INSYS Therapeutics, Inc. - Monotherapy Products in Pipeline, 2014 10 INSYS Therapeutics, Inc. - Phase II, 2014 11 INSYS Therapeutics, Inc. - Phase I, 2014 12 INSYS Therapeutics, Inc. - Preclinical, 2014 13 INSYS Therapeutics, Inc. - Pipeline by Target, 2014 29 INSYS Therapeutics, Inc. - Pipeline by Route of Administration, 2014 30 INSYS Therapeutics, Inc. - Pipeline by Molecule Type, 2014 31 INSYS Therapeutics, Inc. - Pipeline Products by Mechanism of Action, 2014 33 INSYS Therapeutics, Inc. - Recent Pipeline Updates, 2014 34 INSYS Therapeutics, Inc. - Dormant Developmental Projects,2014 35 INSYS Therapeutics, Inc. - Discontinued Pipeline Products, 2014 36
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.